Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end s

Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF Lifesciences, an established contract research organisation, aimed at combining the strengths of Partex's advanced AI & data services technology and Althea’s screening services and compounds. The immediate scope of this exciting partnership is to provide end-to-end services from AI-driven drug discovery to wet lab validations to accelerate drug development.